Use of ceftolozane/tazobactam as salvage therapy for infections due to extensively drug-resistant Pseudomonas aeruginosa

International Journal of Antimicrobial Agents
Aurélien DinhMichel Wolff

Abstract

No abstract listed.

Citations

Mar 2, 2018·Expert Review of Anti-infective Therapy·Daniele Roberto GiacobbeUNKNOWN ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva)
Oct 10, 2018·Current Opinion in Infectious Diseases·Philippe Montravers, Matteo Bassetti
Jan 15, 2020·Antimicrobial Agents and Chemotherapy·Sarah C J JorgensenMichael J Rybak
Mar 30, 2018·Infection·Laura Escolà-VergéBenito Almirante
Nov 13, 2020·Clinical Microbiology Reviews·Dafna YahavLeonard Leibovici
Apr 10, 2021·Antimicrobial Resistance and Infection Control·Laura PuzniakAshley Enstone
Mar 27, 2021·Current Opinion in Neurology·Roland NauHelmut Eiffert

❮ Previous
Next ❯

Related Concepts

Related Feeds

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.